#Medication

Bipolar disorder, a complex mood disorder marked by dramatic oscillations between depression and mania, affects an estimated 40 million people worldwide. It is a condition that not only tests individuals’ emotional resilience but also challenges the medical community in its search for effective, personalized treatments. In a recent episode of NPR’s podcast Short Wave, a renowned psychiatry professor from Johns Hopkins School of Medicine—herself living with bipolar disorder—opened up about her diagnosis, daily management, and the latest advancements in treatment. Her dual role as scientist and patient offers a rare, deeply personal, and scientific insight into a condition that remains stigmatized and often misunderstood in many societies, including Thailand.

A wave of recent research is challenging long-held beliefs about Attention Deficit Hyperactivity Disorder (ADHD), questioning whether the condition is truly a lifelong, biologically fixed disorder and whether the medical model that has dominated diagnosis and treatment actually serves those affected. With global ADHD diagnosis rates soaring and stimulant prescriptions at record levels—mirrored by rising numbers in Thailand—the debate over what ADHD is and how best to help children and adults affected is more urgent than ever. These new perspectives could have a profound impact not only on clinical practice in the West but on the evolving approach to ADHD in Thailand, where both awareness and skepticism about the condition are growing rapidly.